Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04016376 · ClinicalTrials.gov registry record · Phase 4
Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction
A Phase 4 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,507
- Enrollment target
NCT04016376: Completed Phase 4 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04016376 is a Phase 4 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,507 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (191% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04016376, a Phase 4 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,507 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the injection site or sites used for administering pain medication (nerve blocks) before a double mastectomy with immediate reconstruction with tissue expanders reduce the need for pain medication after surgery.
Interventions
- DRUG PVB Protocol
- DRUG PECS-1
- DRUG Serratus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,507 participants |
| Start Date | 2019-07-05 |
| Est. Completion | 2026-02-25 |
| Phase | Phase 4 |
What the finished NCT04016376 record still lists
NCT04016376 is an interventional study that assigns participants to a tested intervention. Its 1,507 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (191% higher).
The record links to 0 conditions, and to 3 interventions - of which PVB Protocol is the first listed.
NCT04016376 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04016376 about?
NCT04016376 is a clinical study titled "Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction". The purpose of this study is to determine if the injection site or sites used for administering pain medication (nerve blocks) before a double mastectomy with immediate reconstruction with tissue expanders reduce the need for pain medication after surgery.
What is the current status of trial NCT04016376?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,507 participants. The study started on 2019-07-05. Estimated completion is 2026-02-25.
What interventions are being tested in trial NCT04016376?
The interventions under investigation include: PVB Protocol (DRUG), PECS-1 (DRUG), Serratus (DRUG).
Who is sponsoring clinical trial NCT04016376?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04016376's enrollment target sits among peer trials
1,507 50th of 2000 higher than 1,950 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07136623 · 1,513 participants
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- NCT05633654 · 1,514 participants · Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI